Covaxin booster dose neutralizes Omicron and Delta variant, says study
eMediNexus, 13 January 2022
remove_red_eye 1112 Views
#Hospital Medicine #Infectious Diseases #Pathology and Lab Medicine #Pharmacist #Public Health #Pulmonary Medicine
Coronavirus Live Count Map India
remove_red_eye 1112 Views
COVID-19 Vaccine Updates
Coronavirus Protocols
#Hospital Medicine #Infectious Diseases #Pathology and Lab Medicine #Pharmacist #Public Health #Pulmonary Medicine
A booster dose of Baharat Biotech’s COVID-19 vaccine, Covaxin, administered 6 months after the primary vaccine series, has been reported to effectively neutralize both Omicron and Delta variants of the coronavirus in a study conducted at Emory University.Bharat Biotech said that the study was conducted using a live virus neutralization assay and it was found that the booster dose of Covaxin evoked strong neutralizing antibody responses against Omicron and Delta. The company stated that 100...
Create Account
Login Now
To read the complete article ,
create a free account.
Sign Up
to instantly read 30000+ free Articles & 1000+ Case Studies
Already registered?
Studies are encouraging, Most studies gave very good response of this vaccine.